- Statement of Changes in Beneficial Ownership (4)
2012年4月27日 - 2:18AM
Edgar (US Regulatory)
|
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
DEADY CONAN R
|
2. Issuer Name
and
Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE
[
IDXX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Corp VP, General Counsel & Sec
|
|
(Last)
(First)
(Middle)
ONE IDEXX DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/24/2012
|
|
(Street)
WESTBROOK, ME 04092
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
|
Common Stock
|
4/24/2012
|
|
M
|
|
2384
|
A
|
$41.935
|
19128
|
D
|
|
|
Common Stock
|
4/24/2012
|
|
M
|
|
1704
|
A
|
$41.935
|
20832
|
D
|
|
|
Common Stock
|
4/24/2012
|
|
M
|
|
3773
|
A
|
$34.37
|
24605
|
D
|
|
|
Common Stock
|
4/24/2012
|
|
M
|
|
3609
|
A
|
$36.09
|
28214
|
D
|
|
|
Common Stock
|
4/24/2012
|
|
S
|
|
14470
|
D
|
$85.3124
(1)
|
13744
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
|
Incentive Stock Option (right to buy)
|
$41.9350
|
4/24/2012
|
|
M
|
|
|
2384
|
(2)
|
2/13/2014
|
Common Stock
|
2384
|
$0
|
0
|
D
|
|
|
Non-Qualfied Stock Option (right to buy)
|
$41.9350
|
4/24/2012
|
|
M
|
|
|
1704
|
(3)
|
2/13/2014
|
Common Stock
|
1704
|
$0
|
0
|
D
|
|
|
Non-Qualified Stock Option (right to buy)
|
$34.37
|
4/24/2012
|
|
M
|
|
|
3773
|
(4)
|
2/13/2016
|
Common Stock
|
3773
|
$0
|
4635
|
D
|
|
|
Non-Qualified Stock Option (right to buy)
|
$53.31
|
4/24/2012
|
|
M
|
|
|
3609
|
(5)
|
2/13/2017
|
Common Stock
|
3609
|
$0
|
8950
|
D
|
|
|
Explanation of Responses:
|
|
(
1)
|
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $85.25 to $85.42, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
|
|
(
2)
|
Grant of options to buy shares of common stock becomes exercisable as to 218 shares on 02/14/2011, and the remaining 2,384 shares on 02/14/2012.
|
|
(
3)
|
Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009 and 02/14/2010, 3,870 shares on 02/14/2011, and the remaining 1,704 shares on 02/14/2012.
|
|
(
4)
|
Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.
|
|
(
5)
|
Grant of options to buy shares of common stock becomes exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.
|
Reporting Owners
|
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
DEADY CONAN R
ONE IDEXX DRIVE
WESTBROOK, ME 04092
|
|
|
Corp VP, General Counsel & Sec
|
|
Signatures
|
|
Jennifer L. Panciocco, Attorney-in-Fact for Conan R. Deady
|
|
4/26/2012
|
|
**
Signature of Reporting Person
|
Date
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 6 2024 まで 7 2024
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 7 2023 まで 7 2024
